Flagship Harbor Advisors’s Editas Medicine EDIT Stock Holding History

Flagship Harbor Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-116	Closed	-$3K	–	846
2020 Q3	$3K	Hold	116	–	–	﹤0.01%	1639
2020 Q2	$3K	Hold	116	–	–	﹤0.01%	1707
2020 Q1	$2K	Hold	116	–	–	﹤0.01%	1635
2019 Q4	$3K	Hold	116	–	–	﹤0.01%	1632
2019 Q3	$2K	Sell	116 -150	-56%	-$3.71K	﹤0.01%	1670
2019 Q2	$6K	Sell	266 -184	-41%	-$4.39K	﹤0.01%	1437
2019 Q1	$11K	Sell	450 -50	-10%	-$1.13K	﹤0.01%	1264
2018 Q4	$11K	Hold	500	–	–	﹤0.01%	1191
2018 Q3	$15K	Hold	500	–	–	﹤0.01%	1223
2018 Q2	$17K	Buy	+500	New	+$17.7K	﹤0.01%	1158

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Flagship Harbor Advisors's EDIT Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Editas Medicine (EDIT) in Q4 2020, closing a stake of 116 shares — an estimated $3K sold.

Flagship Harbor Advisors first reported a position in EDIT in Q2 2018 and held it in 10 quarters. The position peaked at $17K in Q2 2018. 312 funds tracked by Wall St. Rank hold EDIT as of Q4 2020.

Flagship Harbor Advisors reported no remaining Editas Medicine position as of Q4 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 116 Editas Medicine shares in Q4 2020, an estimated $3K.
Flagship Harbor Advisors first reported a position in Editas Medicine in Q2 2018 and held it in 10 quarters.
Flagship Harbor Advisors's Editas Medicine position peaked at $17K in Q2 2018.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.